drugset
drugset / Trial / NCT01513928

A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects

NCT01513928 ↗

Phase 1 Completed 12 enrolled Pfizer
NaSingle-groupOpen-labelBasic science

Summary

This study is designed to compare the pharmacokinetics of three different formulations of Pf-04937319

Timeline

Start
2012-01
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject NERIGLIATIN Small molecule 50 mg —

Indications

No indication recorded.